Cargando…

Endothelial biomarkers in patients with familial Mediterranean fever associated vascular disease and vasculopathy

Detalles Bibliográficos
Autores principales:	Sargsyan, Y, Sargsyan, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597045/ http://dx.doi.org/10.1186/1546-0096-13-S1-O16

Ejemplares similares

Pulmonary hypertension in familial Mediterranean fever: consequence or coincidence?
por: Sargsyan, A, et al.
Publicado: (2015)

Canakinumab therapy in patients with Familial Mediterranean Fever
por: Ugurlu, S, et al.
Publicado: (2015)

Unified modeling of Familial Mediterranean Fever and Cryopyrin Associated Periodic Syndromes
por: Gul, A, et al.
Publicado: (2015)

Familial Mediterranean Fever in childhood: a single center experience
por: Barut, K, et al.
Publicado: (2015)

Investigation of the inflammatory cell migration process in familial Mediterranean fever
por: Ulum, YZ Akkaya, et al.
Publicado: (2015)

Semaphorin 3A, a potential immune regulator in Familial Mediterranean Fever
por: Rimar, D, et al.
Publicado: (2015)

Vasculopathy in transthyretin Val30Met familial amyloid polyneuropathy
por: Koike, Haruki, et al.
Publicado: (2015)

Differential expression of miR-4520a is associated with gain of function mutations in Familial Mediterranean Fever (FMF)
por: Latsoudis, H, et al.
Publicado: (2015)

Familial Mediterranean Fever associated diseases in children
por: Özçakar, ZB, et al.
Publicado: (2015)

Interstitial lung disease in STING-associated vasculopathy with onset in infancy (SAVI): preliminary genotype-phenotype correlation
por: Malle, L, et al.
Publicado: (2015)

Comorbidities in patients with Familial Mediterranean Fever
por: Balci-Peynircioğlu, B, et al.
Publicado: (2015)

Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial
por: Hashkes, PJ, et al.
Publicado: (2011)

Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy
por: Miller, Christopher A, et al.
Publicado: (2014)

Familial Mediterranean Fever and Human autoinflammatory diseases
por: Hovhannisyan, L
Publicado: (2015)

The association of Familial Mediterranean Fever and cryptogenic cirrhosis
por: Baskin, E, et al.
Publicado: (2008)

STING-associated vasculopathy with onset in infancy: new clinical findings and mutation in three Turkish children
por: Eroglu, F Kara, et al.
Publicado: (2015)

Musculoskeletal complaints in patients with Familial Mediterranean Fever
por: Özçakar, ZB, et al.
Publicado: (2015)

Deletion in MEFV resulting in the loss of p.M694 residue as the cause of autosomal dominant familial Mediterranean fever in North Western European Caucasians - a case series and genetic exploration
por: Rowczenio, D, et al.
Publicado: (2015)

Neonatal onset Familial Mediterranean Fever
por: Özçakar, ZB, et al.
Publicado: (2015)

Familial Mediterranean Fever in older children
por: Özdel, Semanur, et al.
Publicado: (2014)

The role of genotype in Familial Mediterranean Fever
por: Özdel, Semanur, et al.
Publicado: (2014)

Do LDE-Methotrexate lipid nanoparticles decrease allograft vasculopathy in rabbit transplanted heart ?
por: Stolf, N, et al.
Publicado: (2013)

Vascular risk in familial Mediterranean fever
por: Rodríguez, Alexander J.
Publicado: (2017)

Articular involvement in childhood Familial Mediterranean Fever
por: Barut, K, et al.
Publicado: (2015)

Quality of life in children with familial Mediterranean fever
por: Öztürk, Ö, et al.
Publicado: (2015)

NOD2/CARD 15 gene mutations in patients with Familial Mediterranean Fever
por: Berkun, Y, et al.
Publicado: (2011)

Exercise-induced changes of CSF vascular endothelial growth factor in adult chronic hydrocephalus patients
por: Luciano, Mark Gregory, et al.
Publicado: (2015)

Screening for inherited metabolic disorders in patients with Familial Mediterranean Fever
por: Kiykim, E, et al.
Publicado: (2015)

L-ficolin and H-ficolin in patients with Familial Mediterranean fever
por: Mkrtchyan, G, et al.
Publicado: (2015)

Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
por: Turgay, S, et al.
Publicado: (2015)

Magnetic resonance imaging features of Familial Mediterranean Fever associated spondyloarthritis
por: Turan, A, et al.
Publicado: (2015)

Challenging case of Familial Mediterranean Fever and its management
por: Al Hosani, A, et al.
Publicado: (2015)

Familial Mediterranean Fever (FMF) and renal disease: first report on 29 Sicilian patients
por: Vitale, A, et al.
Publicado: (2008)

Zytokin profiles in familial Mediterranean fever patients: IL-18 as a major cytokine and potential biomarker or target
por: Igney-Oertel, A, et al.
Publicado: (2015)

Increased frequency of psoriasis in the families of subjects with childhood Familial Mediterranean Fever
por: Barut, Kenan, et al.
Publicado: (2014)

The patient experience of Colchicine Resistant-Familial Mediterranean Fever (cr-FMF)
por: Dandekar, P, et al.
Publicado: (2015)

Evaluation of familial mediterranean fever patients: a single center experience
por: Gulez, P, et al.
Publicado: (2015)

Chronic recurrent multifocal osteomyelitis in a patient with Familial Mediterranean Fever
por: Daia, A, et al.
Publicado: (2015)

Elementary Ca(2+) signals through endothelial TRPV4 channels regulate vascular function
por: Nelson, Mark T, et al.
Publicado: (2013)

PReS-FINAL-2223: The relationship between FMF, BD and epilepsy
por: Sargsyan, H
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hjd1v6cmrfodsnojfae5tugac6